Showa University Northern Yokohama Hospital
Yokohama, Kanagawa, Japan
University hospital in Yokohama
35-1 Chigasakichuo, Tsuzuki Ward, Yokohama, Kanagawa 224-8503
About Showa University Northern Yokohama Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
3
Japan Clinical Cancer Research Organization
2
Japanese CT Colonography Society
1
Showa University
1
Clinical Trials at Showa University Northern Yokohama Hospital
During the past decade, Showa University Northern Yokohama Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
2006-03-01
2010-10-01
Completed
628
Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer
2008-03-01
2011-06-01
Completed
300
Japanese National Computed Tomographic (CT) Colonography Trial
2009-10-01
2017-01-01
Completed
1,257
Analisis of Facors Involved in Antidepressant Treatment Response of Major Depressive Disorder
2008-06-01
2010-03-01
Completed
96
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
2018-06-18
2024-03-19
Recruiting
1,281
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
2018-07-18
2029-04-25
Recruiting
960
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
2018-10-19
2025-03-18
Active, not recruiting
1,177
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Showa University Northern Yokohama Hospital"
#1 collaborator was "Korean Cancer Study Group" with 1 trials as a collaborator and "Taiho Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Showa University Northern Yokohama Hospital
According to Clinical.Site data, the most researched conditions in "Showa University Northern Yokohama Hospital" are
"Ulcerative Colitis" (3 trials), "Gastric Cancer" (2 trials), "Colonic Neoplasms" (1 trials), "Colonic Polyps" (1 trials) and "Major Depressive Disorder" (1 trials). Many other conditions were trialed in "Showa University Northern Yokohama Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Showa University Northern Yokohama Hospital
Most popular intervention types in "Showa University Northern Yokohama Hospital" are "Drug" (6 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Mirikizumab" (2 trials), "CT colonography and optical colonoscopy" (1 trials), "Mirikizumab IV" (1 trials), "Mirikizumab SC" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Showa University Northern Yokohama Hospital
The vast majority of trials in "Showa University Northern Yokohama Hospital" are
7 trials for "All" genders.
Clinical Trials Status at Showa University Northern Yokohama Hospital
Currently, there are NaN active trials in "Showa University Northern Yokohama Hospital".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Showa University Northern Yokohama Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Showa University Northern Yokohama Hospital, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".